Table 1. Baseline demographic, clinical and lymphedema characteristics of patients.

	Group 1 (n=30)				Group 2 (n=30)				p
	n	%	Mean±SD	Median	n	%	Mean±SD	Median
Age (year)			54.3±9.3				55.4±10		0.642
Body mass index (kg/m2)			30.9±5.0				31.6±5.5		0.616
Education									0.184
Illiterate	0	0			0	0
Primary school	15	50			12	40
High school	10	33.3			7	23.3
University	5	16.7			11	36.7
Marital status									0.359
Married	27	90			23	76.7
Single	2	6.7			4	13.3
Widow	1	3.3			3	10
Occupation									0.962
Housewife	17	56.7			16	53.3
Worker	0	0			0	0
Retired	10	33.3			11	36.7
Officer	3	10			3	10
Hand dominance									1
Right	29	96.7			28	93.3
Left	1	3.3			2	6.7
Exercise habit									0.552
Yes	9	30			6	20
No	21	70			24	80
Type of surgery									0.424
Modified radical mastectomy	28	93.3			25	83.3
Lumpectomy	2	6.7			5	16.7
Breast cancer									0.806
Stage 1	3	10			2	6.7
Stage 2	18	60			17	56.7
Stage 3	9	30			11	36.7
Histopathologic diagnosis									0.049
Infiltrative ductal	25	83.3			20	66.7
Infiltrative lobular	2	6.7			6	20
Mix (ductal + lobular)	3	10			1	3.3
Other	0	0			3	10
Adjuvant therapies
Chemotherapy positive	28	93.3			27	90			1.000
Radiotherapy positive	24	80			24	80			1.000
Hormonotherapy positive	23	76.7			22	75.9			1.000
Duration of lymphedema (month)			37.3+33.71	36			34.2+36.3	18	0.543
Dominant side involvement	16	53.3			16	53.3			1.000
Stemmer sign									0.188
Positive	21	70			15	50
Negative	9	30			15	50
SD: Standard deviation.